Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
NLRC5 is an important regulator in antigen presentation and inflammation, and its dysregulation promotes tumor progression. In melanoma, the impact of NLRC5 expression on molecular phenotype, clinical characteristics, and tumor features is largely unknown. In the present study, public datasets from...
Main Authors: | Lei Lv, Qinqin Wei, Zhiwen Wang, Yujia Zhao, Ni Chen, Qiyi Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.690186/full |
Similar Items
-
The use of immunotherapy in the treatment of melanoma
by: Tala Achkar, et al.
Published: (2017-04-01) -
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
by: Akhil Shukla, et al.
Published: (2021-02-01) -
High Expression of NLRC5 is associated with prognosis of gastric cancer
by: Li Yuemei, et al.
Published: (2018-10-01) -
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
by: Diogo Garcia, et al.
Published: (2021-06-01) -
Updates in Therapy for Advanced Melanoma
by: Bhavana P. Singh, et al.
Published: (2016-01-01)